News

Further investigations are needed to clarify the role of twice-daily insulin glargine in patients with type 1 and type 2 diabetes. For now, it is wise to recommend once-daily insulin glargine.
Levemir or Lantus can help with daily management of diabetes. ... If you take Levemir twice per day, separate the doses by 12 hours. Lantus: You usually take Lantus once per day.
The medical name for Lantus is insulin glargine. Lantus is an analogue insulin produced by Sanofi-Aventis. It has a consistent activity from within an hour after injecting up to 24 hours. Lantus can ...
The analysis also indicated that glargine twice daily and detemir once daily were the least likely to cause severe hypoglycemia, the investigators point out. However, ...
- First Randomized Controlled Trial to Show That Basal Plus Regimen Provides more Effective Glycemic Control with Less Hypoglycemia Than with Aspart Premixed Insulin "Comparison of 3 intensified ...
That twice-daily administration leads to dose escalation without proportional gains in glycemic control has been documented for both detemir and glargine, and the mechanisms explained by deVries ...
Levemir and Lantus are both prescription drugs that are used to treat type 1 and type 2 diabetes. Learn how their uses, effectiveness, and side effects compare.
In the study, patients taking Lantus once-daily reported a significantly greater treatment satisfaction over insulin detemir twice-daily, with over 50% less drop-outs (4.6% vs 10.1%, p=0.001).
“We know that many people with type 2 diabetes prefer simplicity, meaning fewer injections and more convenience than what is currently provided with once- or twice-daily basal insulin treatment ...
Once-daily Toujeo was non‑inferior to once‑daily Lantus in HbA1c reduction from baseline to month 6 (difference between groups 0.00% [0.00 mmol/mol], 95% confidence interval ... NPH insulin injected ...
Twice-daily administration of detemir was then allowed to control predinner blood glucose levels if necessary. By contrast, administration of glargine was limited to once-daily in accordance with ...
Product overview. Toujeo is a high‑strength insulin glargine product containing 300 units/ml solution for injection in a pre‑filled pen (Toujeo Summary of Product Characteristics).It is a basal ...